tiprankstipranks
Advertisement
Advertisement
Purple Biotech Unveils Promising IM1240 Preclinical Data From CAPTN-3 Immunotherapy Platform
PremiumCompany AnnouncementsPurple Biotech Unveils Promising IM1240 Preclinical Data From CAPTN-3 Immunotherapy Platform
2M ago
Purple Biotech reports IM1240 demonstrates potent anti-tumor activity
Premium
The Fly
Purple Biotech reports IM1240 demonstrates potent anti-tumor activity
2M ago
Purple Biotech Forms Scientific Advisory Board to Drive CAPTN-3 Tri-Specific Antibody Platform
Premium
Company Announcements
Purple Biotech Forms Scientific Advisory Board to Drive CAPTN-3 Tri-Specific Antibody Platform
2M ago
Purple Biotech Updates March 2026 Corporate Outlook and Pipeline Milestones
PremiumCompany AnnouncementsPurple Biotech Updates March 2026 Corporate Outlook and Pipeline Milestones
3M ago
Purple Biotech regains compliance with Nasdaq
Premium
The Fly
Purple Biotech regains compliance with Nasdaq
4M ago
Purple Biotech Regains Nasdaq Compliance on Minimum Bid Price
Premium
Company Announcements
Purple Biotech Regains Nasdaq Compliance on Minimum Bid Price
4M ago
Upcoming Stock Splits This Week (March 2 to March 6) – Stay Invested
PremiumMarket NewsUpcoming Stock Splits This Week (March 2 to March 6) – Stay Invested
4M ago
Purple Biotech trading halted, news pending
Premium
The Fly
Purple Biotech trading halted, news pending
4M ago
Purple Biotech to implement ADS ratio change
Premium
The Fly
Purple Biotech to implement ADS ratio change
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100